AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34089923 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive response inhibition training (n = 24)
Number of subjects: 49
Study 34089923 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition (n = 25)
Number of subjects: 49
Study 33168097 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified e-learning module
Number of subjects: 98
Study 33168097 — intervention group
Group type: COMPARATOR
Intervention: Current regional prehospital COVID‐19 guidelines (Control)
Number of subjects: 98
Study 33168097 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified e-learning module (subgroup of actively working student paramedics)
Number of subjects: 98
Study 33168097 — intervention group
Group type: COMPARATOR
Intervention: Current regional prehospital COVID‐19 guidelines (subgroup of not actively working student paramedics) (Control)
Number of subjects: 98
Study 36253105 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa/carbidopa 300/75 mg daily for 80 weeks (early-start group)
Number of subjects: 445
Study 36253105 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 40 weeks followed by levodopa/carbidopa 300/75 mg daily for 40 weeks (delayed-start group)
Number of subjects: 445
Study 33992261 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates and dark chocolate intake
Number of subjects: 36
Study 33992261 — intervention group
Group type: COMPARATOR
Intervention: Control group (dark chocolate without exercise)
Number of subjects: 36
Study 33992261 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates and flavanol-free white chocolate
Number of subjects: 36
Study 35685492 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD)
Number of subjects: 129
Study 35685492 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Fat Diet
Number of subjects: 129
Study 35685492 — intervention group
Group type: COMPARATOR
Intervention: Regular Diet
Number of subjects: 129
Study 35685492 — intervention group
Group type: EXPERIMENTAL
Intervention: All dietary groups
Number of subjects: 129
Study 34287399 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based teaching (computer-based multimedia recorded lecture, 3 hours)
Number of subjects: 36
Study 34287399 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face teaching (live lecture, 3 hours)
Number of subjects: 36
Study 36007448 — intervention group
Group type: EXPERIMENTAL
Intervention: EWA program (two‐year specialized woman only treatment including psychiatric, interpersonal and family concerns)
Number of subjects: 200
Study 36007448 — intervention group
Group type: EXPERIMENTAL
Intervention: EWA program
Number of subjects: 200
Study 36007448 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) in a mixed gender setting
Number of subjects: 200
Study 34085324 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral muscle strength training (PMT) and respiratory muscle strength training (RMT) associated with conventional physical therapy, one session a day for 5 days.
Number of subjects: 83
Study 34085324 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy, one session a day for 5 days.
Number of subjects: 83
Study 32826049 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 0
Study 32826049 — intervention group
Group type: COMPARATOR
Intervention: OC
Number of subjects: 0
Study 32826049 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 35606823 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended physiotherapy program comprising six in-clinic physiotherapy sessions over a period of 12 weeks (1x/2 weeks) and an exercise and counselling program provided by the smartphone application.
Number of subjects: 0
Study 35606823 — intervention group
Group type: COMPARATOR
Intervention: Standard care program comprising twelve weekly in-clinic physiotherapy sessions.
Number of subjects: 0
Study 33063291 — intervention group
Group type: EXPERIMENTAL
Intervention: High GPC (D1+BAd107‐4)
Number of subjects: 3
Study 33063291 — intervention group
Group type: COMPARATOR
Intervention: Low GPC (CN16)
Number of subjects: 3
Study 32703244 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinnitus Retraining Therapy (TRT)
Number of subjects: 25
Study 32703244 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Tinnitus Retraining Therapy (Partial TRT)
Number of subjects: 25
Study 32703244 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 25
Study 35320344 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict restrictive fluid strategy with norepinephrine
Number of subjects: 19
Study 35320344 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end‐expiratory pressure
Number of subjects: 19
Study 34948667 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in hypoxic conditions
Number of subjects: 16
Study 34948667 — intervention group
Group type: COMPARATOR
Intervention: Training in normoxic conditions
Number of subjects: 16
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula feeding
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal age <20 years
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal age ≥35 years
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Never married status
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Government-assisted insurance
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hypertension
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Cesarean delivery
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission to neonatal intensive care unit
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic ethnicity
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Education >12 years
Number of subjects: 2329
Study 32521561 — intervention group
Group type: EXPERIMENTAL
Intervention: Nulliparity
Number of subjects: 2329
Study 35907262 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10Hz)
Number of subjects: 43
Study 32089338 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral mental incisive nerve block (MINB) of 1.8 mL of 2% lidocaine with 1:80,000 epinephrine
Number of subjects: 76
Study 32089338 — intervention group
Group type: COMPARATOR
Intervention: Unilateral mental incisive nerve block (MINB) of 1.8 mL of 2% lidocaine with 1:80,000 epinephrine
Number of subjects: 76
Study 35666322 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate (20 mg/kg for 2 weeks on and 10 weeks off, orally for 12 months)
Number of subjects: 0
Study 35666322 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar routine as etidronate for 12 months)
Number of subjects: 0
Study 35666322 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate
Number of subjects: 0
Study 35666322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33031636 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzymatic toothpaste
Number of subjects: 52
Study 33031636 — intervention group
Group type: COMPARATOR
Intervention: Standard fluoridated toothpaste
Number of subjects: 52
Study 37317475 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible cystoscope with disposable sheath
Number of subjects: 60
Study 37317475 — intervention group
Group type: COMPARATOR
Intervention: Standard flexible cystoscopy
Number of subjects: 60
Study 35574454 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-repetition group (adjusted band resistance to complete 10 repetitions at 7-RPE)
Number of subjects: 57
Study 35574454 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-repetition group (selected preferred band resistance and completed repetitions until reaching 7-RPE)
Number of subjects: 57
Study 35574454 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pre-post change scores of both groups
Number of subjects: 57
Study 32895286 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-adapted Expecting intervention
Number of subjects: 60
Study 32895286 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 60
Study 35584010 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 230
Study 35584010 — intervention group
Group type: COMPARATOR
Intervention: Education
Number of subjects: 230
Study 32886811 — intervention group
Group type: EXPERIMENTAL
Intervention: 200,000 U polymyxin B + 40 mg neomycin solution in normal saline (antibiotic)
Number of subjects: 216
Study 32886811 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 216
Study 34570061 — intervention group
Group type: EXPERIMENTAL
Intervention: Texting 4 Relapse Prevention (T4RP)
Number of subjects: 40
Study 34570061 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 40
Study 36268141 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent management system
Number of subjects: 180
Study 34580095 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-exposure prophylaxis (PrEP) characteristics preferences among TGW and MSM
Number of subjects: 1000
Study 35211224 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote-CR
Number of subjects: 11
Study 35211224 — intervention group
Group type: COMPARATOR
Intervention: CB-CR
Number of subjects: 11
Study 33018611 — intervention group
Group type: EXPERIMENTAL
Intervention: Real videos (40 trials)
Number of subjects: 16
Study 33018611 — intervention group
Group type: COMPARATOR
Intervention: Simulated videos (40 trials)
Number of subjects: 16
Study 33904178 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear assessment + brochure
Number of subjects: 664
Study 33904178 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear assessment + brochure + tailored conversation
Number of subjects: 664
Study 33904178 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear assessment
Number of subjects: 664
Study 33904178 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 664
Study 33371108 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhancing quality of life intervention
Number of subjects: 90
Study 33371108 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 35804078 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflex locomotion therapy (RLT)
Number of subjects: 46
Study 35804078 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive movements with gentle joint compression
Number of subjects: 46
Study 35804078 — intervention group
Group type: COMPARATOR
Intervention: Massages (Control)
Number of subjects: 46
Study 34858228 — intervention group
Group type: EXPERIMENTAL
Intervention: C. militaris plus duloxetine
Number of subjects: 59
Study 34858228 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus duloxetine
Number of subjects: 59
Study 35248263 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing exercises (Group DB)
Number of subjects: 40
Study 35248263 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle exercises (Group PFM)
Number of subjects: 40
Study 33934208 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical pudendal nerve stimulation (EPNS)
Number of subjects: 80
Study 33934208 — intervention group
Group type: COMPARATOR
Intervention: Intravesical instillation (II) of heparin and alkalinized lidocaine
Number of subjects: 80
Study 32684216 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher level of PEEP (13-17 cmH2O)
Number of subjects: 100
Study 32684216 — intervention group
Group type: COMPARATOR
Intervention: Lower level of PEEP (8-12 cmH2O)
Number of subjects: 100
Study 35786058 — intervention group
Group type: EXPERIMENTAL
Intervention: PRC-063
Number of subjects: 387
Study 35786058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 387
Study 33148129 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic Control Treatment (PCT)
Number of subjects: 109
Study 33148129 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic-Focused Psychodynamic Psychotherapy (PFPP)
Number of subjects: 109
Study 33218296 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions involving electronic devices, financial incentives, gamification, and specially trained staff
Number of subjects: 0
Study 33218296 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic clinical trials of behavioral interventions
Number of subjects: 0
Study 33218296 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 35679021 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib 60 mg orally once daily
Number of subjects: 258
Study 35679021 — intervention group
Group type: COMPARATOR
Intervention: Placebo with best supportive care
Number of subjects: 258
Study 33906954 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based program with health coaching (8-week intervention, video-guided exercises 6 times a week, weekly health coaching over the telephone)
Number of subjects: 154
Study 33906954 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based program with health coaching
Number of subjects: 154
Study 32592725 — intervention group
Group type: EXPERIMENTAL
Intervention: High caloric food pictures
Number of subjects: 35
Study 32592725 — intervention group
Group type: EXPERIMENTAL
Intervention: Low caloric food pictures
Number of subjects: 35
Study 32592725 — intervention group
Group type: COMPARATOR
Intervention: Neutral pictures
Number of subjects: 35
Study 32592725 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase
Number of subjects: 35
Study 32592725 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular and ovulatory phases
Number of subjects: 35
Study 36174484 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure (SMBP)
Number of subjects: 24
Study 33713841 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-month treatment regimen
Number of subjects: 2500
Study 33713841 — intervention group
Group type: COMPARATOR
Intervention: 6-month standard treatment regimen
Number of subjects: 2500
Study 35726278 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm compression sleeves (COMP)
Number of subjects: 24
Study 35726278 — intervention group
Group type: COMPARATOR
Intervention: Non-compressive placebo forearm sleeves (PLAC)
Number of subjects: 24
Study 35726278 — intervention group
Group type: COMPARATOR
Intervention: No forearm sleeves (CON)
Number of subjects: 24
Study 35349038 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessed poor health status (n = 21, 8%)
Number of subjects: 400
Study 35349038 — intervention group
Group type: COMPARATOR
Intervention: Self-assessed non-poor health status (n = 245, 92%)
Number of subjects: 400
Study 34757964 — intervention group
Group type: EXPERIMENTAL
Intervention: Various pharmacological interventions over the years including anticholinesterases (physostigmine, neostigmine), immunosuppressants (prednisone, azathioprine), intravenous immune globulin, mycophenolate, cyclosporine, tacrolimus, monoclonal antibodies (rituximab, eculizumab)
Number of subjects: 0
Study 34757964 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial interventions in 1927 included adequate feeding, absolute rest in bed, and tonics
Number of subjects: 0
Study 34757964 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine and glycine
Number of subjects: 0
Study 34757964 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressant pharmacological interventions
Number of subjects: 0
Study 34757964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin
Number of subjects: 0
Study 34757964 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer immunosuppressant drugs (mycophenolate, cyclosporine, tacrolimus)
Number of subjects: 0
Study 34757964 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies (rituximab, eculizumab)
Number of subjects: 0
Study 34757964 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trial of drug therapy for myasthenia gravis
Number of subjects: 0
Study 32217018 — intervention group
Group type: EXPERIMENTAL
Intervention: Latin Americans residing in Spain (group A)
Number of subjects: 2687
Study 32217018 — intervention group
Group type: COMPARATOR
Intervention: Latin Americans residing in the United States (group B)
Number of subjects: 2687
Study 36229663 — intervention group
Group type: EXPERIMENTAL
Intervention: Tebentafusp (gp100×CD3), a soluble T cell receptor bispecific
Number of subjects: 127
Study 34473963 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.3% liposomal and 0.25% plain bupivacaine
Number of subjects: 120
Study 34473963 — intervention group
Group type: COMPARATOR
Intervention: 0.25% plain bupivacaine
Number of subjects: 120
Study 33107110 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiposity measures (BMI, waist circumference, subscapular skinfold, middle upper arm circumference)
Number of subjects: 1200
Study 33107110 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI (per kg/m2 increase)
Number of subjects: 1200
Study 33107110 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist circumference (per cm increase)
Number of subjects: 1200
Study 33107110 — intervention group
Group type: EXPERIMENTAL
Intervention: Subscapular skinfold (per mm increase)
Number of subjects: 1200
Study 33107110 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle upper arm circumference (per mm increase)
Number of subjects: 1200
Study 34391298 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual task group (DTG) - 16 dual task training sessions based on the Trail Making Test (TMT)
Number of subjects: 10
Study 34391298 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - Conventional training protocol
Number of subjects: 10
Study 34391298 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual task group (DTG)
Number of subjects: 10
Study 34391298 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 10
Study 32893023 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective Tissue Manipulation (CTM) combined with usual care
Number of subjects: 60
Study 32893023 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal Massage combined with usual care
Number of subjects: 60
Study 32893023 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Alone
Number of subjects: 60
Study 35968511 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/day tandospirone
Number of subjects: 0
Study 35968511 — intervention group
Group type: COMPARATOR
Intervention: 30 mg/day tandospirone
Number of subjects: 0
Study 33252553 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiered prioritization list for orthopaedic procedures
Number of subjects: 63
Study 35655360 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilayer bags with a mixture of 83%N2 + 15%CO2 + 2%O2
Number of subjects: 0
Study 35655360 — intervention group
Group type: COMPARATOR
Intervention: Control (packages without gaseous and alcoholic paper)
Number of subjects: 0
Study 33227558 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐CBT
Number of subjects: 90
Study 33227558 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 90
Study 35868954 — intervention group
Group type: EXPERIMENTAL
Intervention: Outward preparatory gesture
Number of subjects: 18
Study 35868954 — intervention group
Group type: EXPERIMENTAL
Intervention: Inward-upward preparatory gesture
Number of subjects: 18
Study 35868954 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (animated bar and arrow)
Number of subjects: 18
Study 34175270 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid cardiac rehabilitation (CR; usual care) with an additional 3 months offered remotely based on the continuous care model
Number of subjects: 88
Study 34175270 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional 1-month supervised CR)
Number of subjects: 88
Study 32632491 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01 mg/kg intravenous THC
Number of subjects: 0
Study 32632491 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg intravenous THC
Number of subjects: 0
Study 32632491 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ethanol vehicle)
Number of subjects: 0
Study 34891167 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette flavors (green apple, strawberry, chocolate, vanilla, menthol, koolada, peppermint, spearmint, subtle tobacco, full‐flavored tobacco) with nicotine formulations (free-base, salt)
Number of subjects: 119
Study 33394598 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EN), specific dosage and duration not mentioned.
Number of subjects: 0
Study 33394598 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive dose EN into the stomach after initial resuscitation, specific dosage not mentioned.
Number of subjects: 0
Study 36123398 — intervention group
Group type: EXPERIMENTAL
Intervention: Fimasartan
Number of subjects: 341
Study 36123398 — intervention group
Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 341
Study 33982511 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective performance criteria in post-marketing evaluation of TCM injections
Number of subjects: 0
Study 34601386 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis intervention (four weekly sessions plus treatment-as-usual)
Number of subjects: 20
Study 34601386 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control group)
Number of subjects: 20
Study 33010799 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape
Number of subjects: 66
Study 33010799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 35836919 — intervention group
Group type: EXPERIMENTAL
Intervention: Omaha system care group
Number of subjects: 96
Study 35836919 — intervention group
Group type: COMPARATOR
Intervention: Routine care group
Number of subjects: 96
Study 34363307 — intervention group
Group type: EXPERIMENTAL
Intervention: DTM SCS
Number of subjects: 128
Study 34363307 — intervention group
Group type: COMPARATOR
Intervention: Traditional SCS
Number of subjects: 128
Study 33586478 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic proximal DVT
Number of subjects: 7036
Study 33586478 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic VTE
Number of subjects: 7036